
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||
| Inglés Español | ||||||||||||||
| SV TOTAL RNA Isolation System |
||||||||||||||
![]() |
||||||||||||||
| Component Listing for Z3100 | ||||||||||||||
| 10
x 5ea/pack |
Spin
Column Assemblies and Elution Tubes SV RNA Lysis Buffer SV RNA Dilution Buffer B-Mercaptoethsnol (48.7%) Dnase I (Iyophilized) MnCl2, 0.09M Yellow Core Buffer SV Dnase Stop Solution (concentrated) SV RNA Solution Solution (concentrated) Nuclease-Free Water |
|||||||||||||
| Description: The SV Total RNA Isolation System(a.b) provides a fast and simple technique for the preparation of purified and intact total RNA from tissues, cultured cell and white blood cell in as little as one hour. Using this membrane-based purification system, up to 60mg of tissue. The system incorporates a Dnase treatment step directly on the membrane of the minicolumn. This substantially reduces genomic DNA contamination, wich can interfere with amplification-based methodologies. Purification is achieved without the use of phenol/chloroform extractions or ethanol precipitations, and there is no Dnase carryover in the final RNA preparation. Features
Safe and efficient: Rapid isolation of high yields of
total RNA without the use of hazardous compounds like phenol. |
||||||||||||||
| Protocol | ||||||||||||||
| Technical Manual | #TM048 | |||||||||||||
| Storage Conditions: Store at 22-25ºC. Notes: The Miniprep Vaccum Adapters (Cat.# A1331) are required for the vacuum format of the SV Total RNA Isolation System and must be purchased separately. The Vac-Man® (Cat# A7231) and the Vac-Man® Jr. (Cat.# A7660) Laboratory Vacuum Manifolds can be used with the SV Total RNA Isolation System and are available separately. |
||||||||||||||
![]() |
||||||||||||||
| a) Cat.# Z3100. Z3101, Z3141 and Z3051 For Laboratory Use. b) U.S. Pat. No. 6, 218, 531 and other patents pending. |
||||||||||||||
![]() |
||||||||||||||
![]() |
||||||||||||||
| RNA was isolated from 1ml of human blood using the SV Total RNA Isolation System. RT-PCR was performed using the indicated volumes of eluted RNA and primers complementary to human B-actin or human Adenomatous Polyposis Coli (APC) gene with the Promega Access RT-PCR System (Cat.# A1250). | ||||||||||||||
| SUBIR | ||||||||||||||